Rajarshi Guha

Vertex Pharmaceuticals (United States)

Papers

1

Total Citations

20

H-Index

1

About

Rajarshi Guha is a leading figure in computational chemistry and drug discovery, with a primary focus on high-throughput screening and the development of novel algorithms for analyzing complex biological data. His most notable contribution is in the realm of drug combination screening, where he has pioneered methods to efficiently identify synergistic therapeutic pairs. His landmark 2019 paper, "High-Throughput Screening for Drug Combinations," has garnered 20 citations, underscoring its influence in advancing combinatorial drug design. Guha's work bridges cheminformatics and machine learning, enabling researchers to navigate vast chemical spaces and predict drug interactions with greater accuracy. Beyond his research, he is recognized for developing open-source tools that democratize access to sophisticated screening techniques, fostering collaboration across academia and industry. His efforts have not only accelerated the discovery of effective combination therapies for complex diseases but also set new standards for reproducibility in high-throughput experiments. For students and researchers, Guha’s career exemplifies how integrating computational methods with experimental biology can unlock transformative insights in pharmacology.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening for Drug Combinations
20 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Vertex Pharmaceuticals (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago